HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Senores Pharmaceuticals inks agreement to acquire ANDA for Tramadol Tablets
May-09-2025

Senores Pharmaceuticals, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (SPI), has signed agreement to acquire the USFDA-approved Abbreviated New Drug Application (ANDA) for Tramadol Tablets from APDM Pharmaceuticals (APDM). 

Tramadol is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. The acquisition will be funded through the Initial Public Offer (IPO) proceeds raised by company. This is in line with the Objects of the IPO stated in the Red Herring Prospectus.

Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms. 

  RELATED NEWS >>